Kezar Life Sciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -100.0% | – | |
| – | +13.6% | +294.3% | +88.6% | +18.7% | -2.2% | -32.3% | +4.2% | -2.4% | -13.7% | |
| – | – | – | – | – | – | – | – | -114.9% | – | |
| – | -12.3% | +180.4% | +50.9% | +13.2% | +25.7% | +31.0% | +68.0% | -23.3% | -48.7% | |
| – | +41.0% | +189.0% | +51.4% | +19.9% | +31.4% | +28.2% | +31.7% | -11.9% | -20.9% | |
| – | -2.7% | +182.6% | +51.0% | +15.0% | +23.7% | +33.9% | +66.4% | -23.5% | -43.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -86.8% | +645.3% | +30.8% | +2.8% | -14.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -328.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.